DoD Multiple Sclerosis, Clinical Trial Award
The summary for the DoD Multiple Sclerosis, Clinical Trial Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Multiple Sclerosis, Clinical Trial Award: The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, or other early phase trials) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.The FY22 MSRP CTA offers two funding levels (Refer to Section II.D.5, Funding Restrictions). Only one funding level may be chosen per application and the choice of application category is at the discretion of the applicant. The requested budget at each funding level must be justified and appropriate to the scope of the clinical trial proposed. The following are generalized descriptions of the scope of research appropriate for each funding level: Funding Level 1 (FL1) supports small-scale, early-phase, proof-of-principle clinical trials to demonstrate feasibility or inform the design of more advanced trials, or other clinical trials that are appropriate for this funding level. Preliminary data relevant to the proposed clinical trial are required. Funding Level 2 (FL2) supports larger-scale clinical trials at phase 1 or phase 2 that seek to show preliminary evidence of safety or efficacy (benefit of clinical or paraclinical outcomes) in relevant patient populations. Strong justification should be provided, which could include but is not limited to intervention type, trial duration, sample size, outcome measures, assessment tools, and frequency of assessment. Preliminary data relevant to the proposed clinical trial are required.
Federal Grant Title: | DoD Multiple Sclerosis, Clinical Trial Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-22-MSRP-CTA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | October 7th, 2022 |
Original Application Deadline: | October 7th, 2022 |
Posted Date: | April 29th, 2022 |
Creation Date: | April 29th, 2022 |
Archive Date: | November 2nd, 2022 |
Total Program Funding: | $7,700,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 3 |
Cost Sharing or Matching: | No |
Last Updated: | October 3rd, 2022 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DOD Pancreatic Cancer, Translational Research Partnership Award
- • DOD Pancreatic Cancer, Idea Development Award
- • DOD Pancreatic Cancer, Focused Pilot Award
- • DoD Autism, Discovery Award
- • DoD Tick-Borne Disease, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DOD Pancreatic Cancer, Translational Research Partnership Award
- • DOD Pancreatic Cancer, Idea Development Award
- • DOD Pancreatic Cancer, Focused Pilot Award
- • Military Health System Research Program Notice of Funding Opportunity